• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VPS72在结肠癌中的表达分析及相关生物学行为

Expression Analysis of VPS72 and Associated Biological Behaviors in Colon Cancer.

作者信息

Cao Jun, Zhang Hao, Xie Xin, Wang Wei

机构信息

Department of Oncology, The Third Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi, 710061, People's Republic of China.

Department of Surgical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China.

出版信息

Int J Gen Med. 2024 Aug 8;17:3433-3442. doi: 10.2147/IJGM.S465064. eCollection 2024.

DOI:10.2147/IJGM.S465064
PMID:39135633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11318599/
Abstract

BACKGROUND

VPS72 is highly expressed in hepatocellular carcinoma and prostate cancer, participating in various cellular processes such as gene transcription, replication, DNA repair, maintenance of genome integrity, and cancer progression. However, its role in colorectal cancer remains unknown.

METHODS

Bioinformatic methods were used to analyze gene expression, correlation and patient survival. Western blotting, colony formation assays and animal experiments were used to evaluate the function of VPS72 in colon cancer in vivo and in vitro.

RESULTS

VPS72 was highly expressed in colon cancer tissues and correlated with poor overall survival (<0.05) and relapse free survival (<0.01). Furthermore, patients with III/IV clinical stage (<0.001), N1 nodal metastasis (<0.001) or N2 nodal metastasis (<0.05) status had poor overall survival. Further analysis showed that VPS72 is correlated with proliferation and EMT biomarkers. Western blotting, colony formation assays and animal experiments showed that VPS72 overexpression promoted colon cancer proliferation and EMT progress.

CONCLUSION

Our study found that VPS72 was correlated with poor overall survival in colon cancer patients, and high expressed level of VPS72 promoted colon cancer progression, indicating its role as a potential prognosis biomarker.

摘要

背景

VPS72在肝细胞癌和前列腺癌中高表达,参与基因转录、复制、DNA修复、基因组完整性维持及癌症进展等多种细胞过程。然而,其在结直肠癌中的作用尚不清楚。

方法

采用生物信息学方法分析基因表达、相关性及患者生存情况。运用蛋白质免疫印迹法、集落形成试验及动物实验评估VPS72在体内外结肠癌中的功能。

结果

VPS72在结肠癌组织中高表达,与总生存期较差(<0.05)及无复发生存期较差(<0.01)相关。此外,临床分期为III/IV期(<0.001)、N1淋巴结转移(<0.001)或N2淋巴结转移(<0.05)状态的患者总生存期较差。进一步分析表明,VPS72与增殖及上皮-间质转化生物标志物相关。蛋白质免疫印迹法、集落形成试验及动物实验表明,VPS72过表达促进结肠癌增殖及上皮-间质转化进程。

结论

我们的研究发现,VPS72与结肠癌患者总生存期较差相关,且VPS72高表达促进结肠癌进展,表明其作为潜在预后生物标志物的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c133/11318599/425fc41fe6f6/IJGM-17-3433-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c133/11318599/d9ae50184acc/IJGM-17-3433-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c133/11318599/3cb8f5ebf023/IJGM-17-3433-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c133/11318599/b91e5cddb172/IJGM-17-3433-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c133/11318599/425fc41fe6f6/IJGM-17-3433-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c133/11318599/d9ae50184acc/IJGM-17-3433-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c133/11318599/3cb8f5ebf023/IJGM-17-3433-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c133/11318599/b91e5cddb172/IJGM-17-3433-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c133/11318599/425fc41fe6f6/IJGM-17-3433-g0004.jpg

相似文献

1
Expression Analysis of VPS72 and Associated Biological Behaviors in Colon Cancer.VPS72在结肠癌中的表达分析及相关生物学行为
Int J Gen Med. 2024 Aug 8;17:3433-3442. doi: 10.2147/IJGM.S465064. eCollection 2024.
2
Vacuolar protein sorting-associated protein 72 homolog (VPS72) binding to lysine acetyltransferase 5 (KAT5) promotes the proliferation, invasion and migration of hepatocellular carcinoma through regulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway.液泡分选相关蛋白 72 同源物(VPS72)与赖氨酸乙酰转移酶 5(KAT5)结合,通过调节磷脂酰肌醇 3-激酶(PI3K)/蛋白激酶 B(AKT)信号通路促进肝癌的增殖、侵袭和迁移。
Bioengineered. 2022 Apr;13(4):9197-9210. doi: 10.1080/21655979.2022.2056692.
3
Prognostic marker VPS72 could promote the malignant progression of prostate cancer.预后标志物 VPS72 可促进前列腺癌的恶性进展。
BMC Cancer. 2024 Jun 10;24(1):713. doi: 10.1186/s12885-024-12488-z.
4
Targeting VPS72 inhibits ACTL6A/MYC axis activity in HCC progression.靶向 VPS72 抑制 HCC 进展中的 ACTL6A/MYC 轴活性。
Hepatology. 2023 Nov 1;78(5):1384-1401. doi: 10.1097/HEP.0000000000000268. Epub 2023 Jan 13.
5
Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.AXL 的功能及其对鼻咽癌的调控的分子机制。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Jun 28;47(6):685-697. doi: 10.11817/j.issn.1672-7347.2022.210786.
6
High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival.CUL4A和TP53在结直肠癌中的高表达预示着较差的生存率。
Cell Physiol Biochem. 2018;51(6):2829-2842. doi: 10.1159/000496013. Epub 2018 Dec 18.
7
SERPINC1, a new prognostic predictor of colon cancer, promote colon cancer progression through EMT.SERPINC1,一种新的结肠癌预后预测因子,通过 EMT 促进结肠癌的进展。
Cancer Rep (Hoboken). 2024 Jun;7(6):e2079. doi: 10.1002/cnr2.2079.
8
PRR14 overexpression promotes cell growth, epithelial to mesenchymal transition and metastasis of colon cancer via the AKT pathway.PRR14 过表达通过 AKT 通路促进结肠癌的细胞生长、上皮间质转化和转移。
PLoS One. 2019 Oct 9;14(10):e0218839. doi: 10.1371/journal.pone.0218839. eCollection 2019.
9
MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.MEGF6通过TGFβ/SMAD信号通路促进结直肠癌转移中的上皮-间质转化
Cell Physiol Biochem. 2018;46(5):1895-1906. doi: 10.1159/000489374. Epub 2018 Apr 26.
10
ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer.ACTL6A 表达促进结肠癌的侵袭、转移和上皮间质转化。
BMC Cancer. 2018 Oct 22;18(1):1020. doi: 10.1186/s12885-018-4931-3.

引用本文的文献

1
Identification of tumor immune infiltration-associated VPS72 and prognostic significance of VPS72 and CD8A in hepatocellular carcinoma.肿瘤免疫浸润相关的VPS72的鉴定及VPS72和CD8A在肝细胞癌中的预后意义
Discov Oncol. 2025 Mar 27;16(1):410. doi: 10.1007/s12672-025-02017-0.

本文引用的文献

1
Evaluation of Serum Cytokeratines, Thymidine Kinase, and Growth Factors as Cancer Biomarkers in Colorectal Cancer.血清细胞角蛋白、胸苷激酶和生长因子在结直肠癌中的评估作为癌症生物标志物。
Anticancer Res. 2024 Jul;44(7):3105-3113. doi: 10.21873/anticanres.17124.
2
The Glasgow Microenvironment Score: an exemplar of contemporary biomarker evolution in colorectal cancer.格拉斯哥微环境评分:结直肠癌当代生物标志物演进的范例。
J Pathol Clin Res. 2024 Jul;10(4):e12385. doi: 10.1002/2056-4538.12385.
3
Explore Key Genes and Mechanisms Involved in Colon Cancer Progression Based on Bioinformatics Analysis.
基于生物信息学分析探讨结肠癌进展相关的关键基因和机制。
Appl Biochem Biotechnol. 2024 Sep;196(9):6253-6268. doi: 10.1007/s12010-023-04812-3. Epub 2024 Jan 31.
4
Cancer of colon, rectum and anus: the rising burden of disease worldwide from 1990 to 2019.结肠癌、直肠癌和肛门癌:1990 年至 2019 年全球疾病负担的上升。
J Public Health (Oxf). 2024 Feb 23;46(1):20-29. doi: 10.1093/pubmed/fdad197.
5
Alterations in the Epigenetic Machinery Associated with Prostate Cancer Health Disparities.与前列腺癌健康差异相关的表观遗传机制改变
Cancers (Basel). 2023 Jul 1;15(13):3462. doi: 10.3390/cancers15133462.
6
VPS72, a member of VPS protein family, can be used as a new prognostic marker for hepatocellular carcinoma.VPS72,VPS 蛋白家族的一员,可作为肝细胞癌的一个新的预后标志物。
Immun Inflamm Dis. 2023 May;11(5):e856. doi: 10.1002/iid3.856.
7
Colorectal cancer: Review of signaling pathways and associated therapeutic strategies.结直肠癌:信号通路综述及相关治疗策略。
J Surg Oncol. 2023 Jun;127(8):1277-1295. doi: 10.1002/jso.27295.
8
Targeting VPS72 inhibits ACTL6A/MYC axis activity in HCC progression.靶向 VPS72 抑制 HCC 进展中的 ACTL6A/MYC 轴活性。
Hepatology. 2023 Nov 1;78(5):1384-1401. doi: 10.1097/HEP.0000000000000268. Epub 2023 Jan 13.
9
Wnt signaling in colorectal cancer: pathogenic role and therapeutic target.结直肠癌中的 Wnt 信号通路:致病作用和治疗靶点。
Mol Cancer. 2022 Jul 14;21(1):144. doi: 10.1186/s12943-022-01616-7.
10
Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家结直肠癌及其危险因素负担,1990-2019 年:2019 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2022 Jul;7(7):627-647. doi: 10.1016/S2468-1253(22)00044-9. Epub 2022 Apr 7.